Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Dermatologic 1Classical hematology 1

Conditions

Tobacco Use Disorder 1Mouth Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Fanconi Anemia 1Erythroplasia 1

Interventions

pembrolizumab 2Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2trastuzumab deruxtecan 1motexafin gadolinium 1cabozantinib 1brodalumab 1Tomography, Optical Coherence 1Taxes 1Surveys and Questionnaires 1Spectrometry, Fluorescence 1Sentinel Lymph Node Biopsy 1Ritonavir 1Radiotherapy 1Psychology, Positive 1Pemetrexed 1Paclitaxel 1Optical Imaging 1Molecular Diagnostic Techniques 1Methods 1Ipilimumab 1Indinavir 1Etoposide 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × Spectrometry, Fluorescence × Dermatologic × Clear all
NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
338 enrolled
Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡